Welcome to our new website! If this is the first time you are logging in on the new site, you will need to reset your password. Please contact us at raps@raps.org if you need assistance.
Your membership opens the door to free learning resources on demand. Check out the Member Knowledge Center for free webcasts, publications and online courses.
Hear from leaders around the globe as they share insights about their experiences and lessons learned throughout their certification journey.
The Learning Portal will be under maintenance Monday, 6 December between 6 AM and 5 PM EST. Portal functionality will be unavailable during this window. We apologize for any inconvenience caused during this time.
RAPS is the largest global organization of and for those involved with the regulation of healthcare and related products, including medical devices, pharmaceuticals, biologics and nutritional products. Founded in 1976, RAPS helped establish the regulatory profession and continues to actively support the professional and lead the profession as a neutral, non-lobbying nonprofit organization.
Stay informed on the latest healthcare regulatory news through RAPS’ online magazine, Regulatory Focus and its companion daily e-newsletter RF Today, or by following RAPS on social media, including Twitter, LinkedIn and Facebook.
Reporters, bloggers and other members of the media interested in covering RAPS events or programs should contact Zachary Brousseau, senior manager of communications, at zbrousseau@raps.org or by calling +301 770 2920 ext. 245.
Posted 30 November 2021 | By Zachary Brousseau
RAPS today announced the release of its updated Regulatory Competency Framework, describing the essential elements of what is required of regulatory professionals at four key career and profes...
Posted 15 September 2021 | By Zachary Brousseau
RAPS today wrapped up its annual RAPS Convergence, the world’s largest conference dedicated to healthcare product regulation and regulatory issues. The event drew more than 1,500 participants ...
Nearly 100,000 professionals around the world currently work in the field of regulatory affairs for healthcare products, such as pharmaceuticals, medical devices, and biotechnology products, i...
Posted 09 September 2021 | By Zachary Brousseau
RAPS has recognized seven distinguished professionals and one patient advocacy organization with awards for their work to support the regulatory profession and advance public health. RAPS’ Fou...
Posted 02 September 2021 | By Zachary Brousseau
RAPS today announced that Orin Chisholm, Robert Falcone, Chin-Wei Soo and Beat Steffen have been selected to join the venerated ranks of RAPS Fellows.
Posted 26 August 2020 | By Maia Anderson
...new data required from drugmakers under the Coronavirus Aid, Relief, and Economic Security Act next month, though the measure is set to take effect Sept. 23, Regulatory Focus reported.
Posted 22 August 2020
According to Regulatory Affairs Professional Society (RAPS), it will take a fast-tracked vaccine development anywhere between 12 and 18 months to be marketed commercially...
Posted 21 August 2020 | By Deborah D'Souza
Source: Regulatory Affairs Professionals Society...
Posted 17 August 2020 | By Angie Stewart
...required to notify the FDA of events that could disrupt the supply of a device during the public health emergency, according to the Regulatory Affairs Professionals Society.
Posted 15 August 2020 | By Jess Bauldry
...19 vaccines are being developed around the world, according to the Regulatory Affairs Professional Society. Currently ...